The safety and efficacy of hydroxyurea in 2 to 5 year old children with sickle cell disease

被引：0

作者：

Hoppe, C ^{[1
]}

Van Warmerdam, J ^{[1
]}

Allen, K ^{[1
]}

Quirolo, K ^{[1
]}

Vichinsky, E ^{[1
]}

Styles, L ^{[1
]}

机构：

[1] Childrens Hosp Oakland, Oakland, CA USA

来源：

PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

859

引用

页码：147A / 147A

页数：1

共 50 条

[31] Alterations in the Humoral Immunophenotype of Children with Sickle Cell Disease on Hydroxyurea [J].

Vistica-Sampino, Emily ;

Chorzalska, Anna D. ;

Bonal, Dennis M. ;

Morgan, John ;

Nguyen, Lisa ;

Rodriguez, Anaelena ;

Lulla, Rishi ;

Dubielecka, Patrycja M. .

BLOOD, 2022, 140 :2523-2525

[32] Role of hydroxyurea (HU) in children with sickle cell disease (SCD) [J].

Motwani, J ;

Lawson, SE ;

Darbyshire, PJ .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 :24-25

[33] Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease [J].

Pashankar, Farzana D. ;

Manwani, Deepa ;

Lee, Margaret T. ;

Green, Nancy S. .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (03) :242-243

[34] Genetic Predictors of Hydroxyurea Response in Children with Sickle Cell Disease [J].

McDade, Jenny ;

Flanagan, Jonathan M. ;

Mortier, Nicole ;

Smeltzer, Matthew ;

Howard, Thad A. ;

Cone, Amy ;

Hankins, Jane ;

Aygun, Banu ;

Wu, Song ;

Ware, Russell E. .

BLOOD, 2009, 114 (22) :338-338

[35] When Should Hydroxyurea Be Used for Children With Sickle Cell Disease? [J].

Mueller, Brigitta U. .

PEDIATRICS, 2008, 122 (06) :1365-1366

[36] Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease [J].

Telen, Marilyn J. .

BLOOD, 2016, 127 (07) :810-819

[37] INTERIM SAFETY AND EFFICACY OF VOXELOTOR IN CHILDREN AGED 2 to <4 YEARS WITH SICKLE CELL DISEASE [J].

Fuh, Beng ;

Inati, Adlette ;

Inusa, Baba ;

Abboud, Miguel ;

Norris, Cynthia ;

Kalpatthi, Ramasubramanian ;

Telfer, Paul ;

Trompeter, Sara ;

Dixon, Sandy ;

Enriquez, Aimee ;

Akhlaghi, Fatemeh ;

Smith-Whitley, Kim ;

Brown, Clark .

PEDIATRIC BLOOD & CANCER, 2023, 70 :S163-S164

[38] Consent, compliance, toxicity and efficacy of hydroxyurea therapy in sickle cell disease [J].

Hilliard, LM ;

Schwartz, J ;

Collins, HC ;

Howard, TH .

PEDIATRIC RESEARCH, 2003, 53 (04) :277A-277A

[39] SAFETY AND EFFICACY OF HYDROXYUREA IN CHILDREN AND ADOLESCENTS WITH SICKLE/BETA-THALASSEMIA: THE GREEK EXPERIENCE [J].

Papadopoulou, E. ;

Economou, M. ;

Teli, A. ;

Zafeiriou, D. ;

Athanassiou-Metaxa, M. ;

Gompakis, N. ;

Papachristou, F. .

HAEMATOLOGICA, 2012, 97 :168-168

[40] Hydroxyurea (hydroxycarbamide) for sickle cell disease [J].

Rankine-Mullings, Angela E. ;

Nevitt, Sarah J. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (09)

← 1 2 3 4 5 →